Raclopride
Raclopride is a synthetic compound known for its role as a selective antagonist at dopamine D2 and D3 receptors. It is used in scientific research to study the dopaminergic system, particularly in relation to Parkinson's disease, schizophrenia, and drug addiction.
Chemistry
Raclopride belongs to the chemical class of phenylpiperidines. It is a derivative of benzamide and is structurally related to other benzamide antipsychotics such as sulpiride and tiapride. The compound is chiral, and the form used in research is usually the more active (S)-(-)-enantiomer.
Pharmacology
Raclopride acts as a competitive antagonist at D2 and D3 dopamine receptors. This means it binds to these receptors without activating them, thereby blocking the effects of endogenous dopamine or other agonists. Raclopride has high affinity for D2 and D3 receptors and negligible affinity for other dopamine receptor subtypes.
Uses in Research
Raclopride is widely used in animal and human research to study the function of the dopaminergic system. It is commonly used in Positron Emission Tomography (PET) studies to measure dopamine receptor availability and the release of endogenous dopamine. In these studies, a radiolabelled form of raclopride is injected into the subject and its distribution in the brain is measured using PET imaging.
Clinical Significance
The ability of raclopride to block D2 and D3 receptors has made it a useful tool in the study of various neurological and psychiatric disorders. These include Parkinson's disease, where it has been used to investigate the role of dopamine in motor function, and schizophrenia, where it has been used to study the hypothesized overactivity of the dopaminergic system. Raclopride has also been used in research into drug addiction, to investigate the role of dopamine in reward and reinforcement.
See Also
This article is a neuroscience stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
